AAAAAA

   
Results: 1-10 |
Results: 10
IDENTIFICATION OF THE HUMAN LIVER CYTOCHROME-P450 ENZYMES INVOLVED INTHE IN-VITRO METABOLISM OF A NOVEL 5-LIPOXYGENASE INHIBITOR
Authors: MACHINIST JM MAYER MD ROBERTS EM SURBER BW RODRIGUES AD
Citation: Jm. Machinist et al., IDENTIFICATION OF THE HUMAN LIVER CYTOCHROME-P450 ENZYMES INVOLVED INTHE IN-VITRO METABOLISM OF A NOVEL 5-LIPOXYGENASE INHIBITOR, Drug metabolism and disposition, 26(10), 1998, pp. 970-976
PHARMACOKINETICS OF ZILEUTON AND ITS METABOLITES IN PATIENTS WITH RENAL IMPAIRMENT
Authors: AWNI WM WONG S CHU SY PATTERSON K HANSEN R MACHINIST JM DRAJESK J KEANE WF HALSTENSON CE
Citation: Wm. Awni et al., PHARMACOKINETICS OF ZILEUTON AND ITS METABOLITES IN PATIENTS WITH RENAL IMPAIRMENT, Journal of clinical pharmacology, 37(5), 1997, pp. 395-404
LANSOPRAZOLE PHARMACOKINETICS IN SUBJECTS WITH VARIOUS DEGREES OF KIDNEY-FUNCTION
Authors: KAROL MD MACHINIST JM CAVANAUGH JM
Citation: Md. Karol et al., LANSOPRAZOLE PHARMACOKINETICS IN SUBJECTS WITH VARIOUS DEGREES OF KIDNEY-FUNCTION, Clinical pharmacology and therapeutics, 61(4), 1997, pp. 450-458
PHARMACOKINETICS OF ZILEUTON AND ITS METABOLITES IN SUBJECTS WITH RENAL IMPAIRMENT
Authors: AWNI WM WONG S CHU SY PATTERSON K HANSEN R MACHINIST JM DRAJESK J KEANE WF HALSTENSON CE
Citation: Wm. Awni et al., PHARMACOKINETICS OF ZILEUTON AND ITS METABOLITES IN SUBJECTS WITH RENAL IMPAIRMENT, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 90-90
HEPATIC PEROXISOMAL AND DRUG-METABOLIZING ACTIVITY IN CD-1 MICE AFTERORAL TREATMENT WITH A NOVEL 5-LIPOXYGENASE INHIBITOR
Authors: RODRIGUES AD MACHINIST JM
Citation: Ad. Rodrigues et Jm. Machinist, HEPATIC PEROXISOMAL AND DRUG-METABOLIZING ACTIVITY IN CD-1 MICE AFTERORAL TREATMENT WITH A NOVEL 5-LIPOXYGENASE INHIBITOR, Toxicology and applied pharmacology, 137(2), 1996, pp. 193-201
THE PHARMACOKINETIC PHARMACODYNAMIC INTERACTION BETWEEN ZILEUTON AND TERFENADINE/
Authors: AWNI WM CAO G KASIER JF LOCKE CS MACHINIST JM DUBE LM
Citation: Wm. Awni et al., THE PHARMACOKINETIC PHARMACODYNAMIC INTERACTION BETWEEN ZILEUTON AND TERFENADINE/, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 61-61
PHARMACOKINETICS OF LANSOPRAZOLE IN HEMODIALYSIS-PATIENTS
Authors: KAROL MD MACHINIST JM CAVANAUGH JM
Citation: Md. Karol et al., PHARMACOKINETICS OF LANSOPRAZOLE IN HEMODIALYSIS-PATIENTS, Journal of clinical pharmacology, 35(8), 1995, pp. 815-820
IDENTIFICATION OF THE HUMAN LIVER CYTOCHROME-P450 ENZYMES INVOLVED INTHE METABOLISM OF ZILEUTON (ABT-077) AND ITS N-DEHYDROXYLATED METABOLITE, ABBOTT-66193
Authors: MACHINIST JM MAYER MD SHET MS FERRERO JL RODRIGUES AD
Citation: Jm. Machinist et al., IDENTIFICATION OF THE HUMAN LIVER CYTOCHROME-P450 ENZYMES INVOLVED INTHE METABOLISM OF ZILEUTON (ABT-077) AND ITS N-DEHYDROXYLATED METABOLITE, ABBOTT-66193, Drug metabolism and disposition, 23(10), 1995, pp. 1163-1174
THE IN-VITRO HEPATIC-METABOLISM OF ABT-418, A CHOLINERGIC CHANNEL ACTIVATOR, IN RATS, DOGS, CYNOMOLGUS MONKEYS, AND HUMANS
Authors: RODRIGUES AD FERRERO JL AMANN MT ROTERT GA CEPA SP SURBER BW MACHINIST JM TICH NR SULLIVAN JP GARVEY DS FITZGERALD M ARNERIC SP
Citation: Ad. Rodrigues et al., THE IN-VITRO HEPATIC-METABOLISM OF ABT-418, A CHOLINERGIC CHANNEL ACTIVATOR, IN RATS, DOGS, CYNOMOLGUS MONKEYS, AND HUMANS, Drug metabolism and disposition, 22(5), 1994, pp. 788-798
MEASUREMENT OF LIVER MICROSOMAL CYTOCHROME-P450 (CYP2D6) ACTIVITY USING [O-METHYL-C-14] DEXTROMETHORPHAN
Authors: RODRIGUES AD KUKULKA MJ SURBER BW THOMAS SB UCHIC JT ROTERT GA MICHEL G THOMEKROMER B MACHINIST JM
Citation: Ad. Rodrigues et al., MEASUREMENT OF LIVER MICROSOMAL CYTOCHROME-P450 (CYP2D6) ACTIVITY USING [O-METHYL-C-14] DEXTROMETHORPHAN, Analytical biochemistry, 219(2), 1994, pp. 309-320
Risultati: 1-10 |